Comparative study between a gravity-based and peristaltic pump for intravenous infusion with respect to the generation of proteinaceous microparticles
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Comparative study between a gravity-based and peristaltic pump for intravenous infusion with respect to the generation of proteinaceous microparticles. / Hada, Shavron; Ji, Sunkyong; Lee, Ye Na; Kim, Ki Hyun; Maharjan, Ravi; Kim, Nam Ah; Rantanen, Jukka; Jeong, Seong Hoon.
In: International Journal of Pharmaceutics, Vol. 642, 123091, 2023.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Comparative study between a gravity-based and peristaltic pump for intravenous infusion with respect to the generation of proteinaceous microparticles
AU - Hada, Shavron
AU - Ji, Sunkyong
AU - Lee, Ye Na
AU - Kim, Ki Hyun
AU - Maharjan, Ravi
AU - Kim, Nam Ah
AU - Rantanen, Jukka
AU - Jeong, Seong Hoon
N1 - Funding Information: This study was supported by the National Research Foundation of Korea grant funded by the Korean government (NRF-2018R1A5A2023127 and NRF-2019R1A2C1083911). Special thanks to Hanvit MD for designing the accurate gravity-based infusion system with technical support from the Korea Aerospace Research Institute. Publisher Copyright: © 2023 Elsevier B.V.
PY - 2023
Y1 - 2023
N2 - Subvisible particles generated during the preparation or administration of biopharmaceuticals might increase the risk of immunogenicity, inflammation, or organ dysfunction. To investigate the impact of an infusion system on the level of subvisible particles, we compared two types of infusion sets based on peristaltic movement (Medifusion DI-2000 pump) and a gravity-based infusion system (Accu-Drip) using intravenous immunoglobulin (IVIG) as a model drug. The peristaltic pump was found to be more susceptible to particle generation compared to the gravity infusion set owing to the stress generated due to constant peristaltic motion. Moreover, the 5-µm in-line filter integrated into the tubing of the gravity-based infusion set further contributed to the reduction of particles mostly in the range ≥ 10 µm. Furthermore, the filter was also able to maintain the particle level even after the pre-exposure of samples to silicone oil-lubricated syringes, drop shock, or agitation. Overall, this study suggests the need for the selection of an appropriate infusion set equipped with an in-line filter based on the sensitivity of the product.
AB - Subvisible particles generated during the preparation or administration of biopharmaceuticals might increase the risk of immunogenicity, inflammation, or organ dysfunction. To investigate the impact of an infusion system on the level of subvisible particles, we compared two types of infusion sets based on peristaltic movement (Medifusion DI-2000 pump) and a gravity-based infusion system (Accu-Drip) using intravenous immunoglobulin (IVIG) as a model drug. The peristaltic pump was found to be more susceptible to particle generation compared to the gravity infusion set owing to the stress generated due to constant peristaltic motion. Moreover, the 5-µm in-line filter integrated into the tubing of the gravity-based infusion set further contributed to the reduction of particles mostly in the range ≥ 10 µm. Furthermore, the filter was also able to maintain the particle level even after the pre-exposure of samples to silicone oil-lubricated syringes, drop shock, or agitation. Overall, this study suggests the need for the selection of an appropriate infusion set equipped with an in-line filter based on the sensitivity of the product.
KW - Flow imaging
KW - Gravity infusion
KW - Infusion pump
KW - Peristaltic pump
KW - Protein aggregation
KW - Subvisible particle
U2 - 10.1016/j.ijpharm.2023.123091
DO - 10.1016/j.ijpharm.2023.123091
M3 - Journal article
C2 - 37268032
AN - SCOPUS:85161560776
VL - 642
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
SN - 0378-5173
M1 - 123091
ER -
ID: 357272807